BLRX Price Targets and Analyst Ratings NASDAQ:BLRX
BLRX Forecast. What You Should Know.
BLRX Historical Ratings and Targets
About BioLineRx Ltd.
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.